(Q39245778)

English

Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors (English)

1 reference

Europe PubMed Central

10 September 2017

author name string

Sabrina Campisano

1

1 reference

Europe PubMed Central

10 September 2017

Soledad Mac Keon

2

1 reference

Europe PubMed Central

10 September 2017

Silvina Gazzaniga

3

1 reference

Europe PubMed Central

10 September 2017

María Sol Ruiz

4

1 reference

Europe PubMed Central

10 September 2017

Martín Dodes Traian

5

1 reference

Europe PubMed Central

10 September 2017

José Mordoh

6

1 reference

Europe PubMed Central

10 September 2017

Rosa Wainstok

7

1 reference

Europe PubMed Central

10 September 2017

language of work or name

0 references

publication date

10 November 2012

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

31

1 reference

Europe PubMed Central

10 September 2017

354-361

1 reference

Europe PubMed Central

10 September 2017

2

1 reference

Europe PubMed Central

10 September 2017

Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Harnessing dendritic cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Limitations with in vitro production of dendritic cells using cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cell vaccination and immune monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cells: a critical player in cancer therapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Generation of immunogenic and tolerogenic clinical-grade dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Murine neutrophils present Class II restricted antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

The emergence of basophils as antigen-presenting cells in Th2 inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Neutrophils: Cinderella of innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Interferon-gamma activation of polymorphonuclear neutrophil function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Eosinophils induce DC maturation, regulating immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Mouse bone marrow contains large numbers of functionally competent neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Neutrophil activation and survival are modulated by interaction with NK cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Development of dendritic-cell lineages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Review of murine dendritic cells: types, location, and development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Macrophages as APC and the dendritic cell myth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

The induction of tolerance by dendritic cells that have captured apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

The neutrophil as a cellular source of chemokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Close encounters of neutrophils and DCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Neutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Two way communication between neutrophils and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.114

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.10.114

1 reference

Europe PubMed Central

10 September 2017

release_fholx6iy4jg4xaztbpsmkkhktm

0 references

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39245778&oldid=1815862436"